SEMAGLUTIDE
SEMAGLUTIDE
Semaglutide 10mg
Semaglutide combines the effectiveness of a GLP-1 receptor agonist with an appetite suppressant to create an effective dual approach for weight management. By mimicking the action of human incretin glucagon-like peptide-1, this medication increases insulin production in the body and balances it out, resulting in suppressed appetites that can lead to caloric reductions and ultimately substantial weight loss simply by eating less.
Description
Semaglutide (GLP-1) and glucagon-like peptide 1 are short, natural peptides. The naturally occurring hormone is only 31 amino acids in length, with a primary physiological function to lower blood sugar levels by naturally increasing insulin secretion. It also appears to protect beta-cell insulin stores by promoting the transcription of insulin genes and is associated with neurotrophic effects in the central nervous system and the brain. Studies in the GI system have observed that Semaglutide may significantly reduce appetite by slowing gastric emptying and bowel motility. Preliminary studies have also suggested the potential effects of Semaglutide on the heart, fat, muscles, bones, liver, lungs, lungs, and kidneys.